USP26 Promotes Non-Small Cell Lung Cancer Progression via Deubiquitination and Stabilization of Gαs.
It is demonstrated that USP26 functions as an oncogenic driver in NSCLC by stabilizing Gαs and suppressing autophagy, highlighting its potential as a prognostic biomarker and therapeutic target.